Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2− Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2− Metastatic Breast Cancer

Published:2018-06-26 Issue:8 Volume:35 Page:1251-1264
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Guérin Annie,Goldschmidt Debbie,Small Tania,Gagnon-Sanschagrin Patrick,Romdhani Hela,Gauthier Genevieve,Kelkar Sneha,Wu Eric Q.,Niravath Polly,Dalal Anand A.

Funder

Novartis Pharmaceuticals Corporation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s12325-018-0740-y/fulltext.html

Reference25 articles.

1. American Cancer Society. Cancer facts & figures 2017 2017. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html . Accessed 26 July 2017.

2. Howlader N, Noone AM, Krapcho M, Miller D BK, Kosary CL, Yu M, et al. SEER Cancer statistics review, 1975-2014 Bethesda, MD: National Cancer Institute; 2017 based on November 2016 SEER data submission. https://seer.cancer.gov/csr/1975_2014/ . Accessed 3 July 2017.

3. Pritchard KI, Gelmon KA, Rayson D, Provencher L, Webster M, McLeod D, et al. Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement. Curr Oncol. 2013;20(1):48–61.

4. Lewis S, Willis K, Yee J, Kilbreath S. Living well? strategies used by women LIVING with metastatic breast cancer. Qual Health Res. 2016;26(9):1167–79.

5. NIH—National Cancer Institute. Metastatic cancer. https://www.cancer.gov/types/metastatic-cancer .

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular complications of ribociclib in breast cancer patients;Critical Reviews in Oncology/Hematology;2024-04